ALX Oncology
ALXO
ALXO
92 hedge funds and large institutions have $83.1M invested in ALX Oncology in 2024 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 34
72% less capital invested
Capital invested by funds: $293M → $83.1M (-$210M)
Holders
92
Holding in Top 10
1
Calls
$364K
Puts
$62K
Top Buyers
| 1 | +$7.65M | |
| 2 | +$1.23M | |
| 3 | +$832K | |
| 4 |
Two Sigma Advisers
New York
|
+$788K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$773K |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$11.4M | |
| 3 | -$9.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.55M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.83M |